Market open · Delayed intraday data · 12:06 PM ET
Last update: Sep 25, 2026, 12:03 PM ET
Humana Inc.
$410.84▲ 8.02% today
Market Open

Why Humana Inc. (HUM) stock moved

Updated Sep 25, 2026

Humana Inc. (HUM) shares climbed 8.0% to $410.84 as of September 25, 2026, a significant gain from the prior close of $380.32. BestStocks flagged the session as a major change for HUM. Below, we break down what changed for HUM, why it matters for investors, how the stock reacted, and the catalysts on the calendar.

What happened

HUM climbed 8.0% to $410.84

Humana Inc. moved +6.94% intraday from $380.32 to $406.73. Humana (HUM) shares are trading higher as part of a broader healthcare sector rebound and rotation into defensive equities following recent Federal Reserve interest rate moves. ### 📊 Market Drivers - Sector Rebound: Tracking general strength in the Health Care Select Sector SPDR Fund (XLV). - Defensive Rotation: Investors moving back into stable, defensive healthcare names after macro rate adjustments. - Underlying Momentum: Continued residual support from robust Q2 earnings ($7.61 EPS vs. $7.27 estimated) and ongoing institutional interest. ### ⚠️ Headwinds & Watchpoints - Medicare Advantage Pressure: Ongoing policy scrutiny, margin adjustments, and plan trimming across the industry. - Cost Trends: Rising medical cost utilization continues to pose a medium-term risk to insurer profit margins. If you want to look closer at Humana, tell me: - Are you looking at short-term trading or long-term holding? - Would you like a comparison against UnitedHealth (UNH) or other peers? Monitor for follow-through at the close.

This summary describes the catalyst and move as first detected on Sep 25, 2026, 11:13 AM EDT; the stock has continued trading since, so the current price and percentage move (shown above) may be larger or smaller than the figures here.
ActivityLow confidence
Rel. volume
0.6×
Below Avg
Vs peers
—
No comparable peers
Market cap
$49.3B
New York Stock Exchange
Analyst target
$424
+3.3% vs price
Price chart
Aug 25 – Sep 25
VVVVVEE$371$391$412Aug 25Sep 2Sep 10Sep 18Sep 25
E earnings
F filing
A analyst
V/N other
click a marker to highlight
Change events — click to jump to details

What it means for Humana Inc. investors

For Humana Inc. investors, the balance of recent signals points to a bullish shift. On the constructive side: Material positive event; Strong 8.0% price move on light volume. Weighing against that: Humana filed earnings today along with two material event 8-K filings (hum-20260728.htm and hum-20260729.htm), triggering a sharp 7.75% intraday decline to $358.60; Humana Inc. (HUM) moved -5.22% from $407.78 to $386.48 on 2026-07-16. Wall Street's consensus price target sits at $424.21, implying +3.3% upside from $410.84. Over the past 90 days analysts logged 3 upgrades and 1 downgrade. BestStocks rates the overall signal quality low (55/100). With earnings roughly 42 days out, the next report is the most likely near-term test of the move.

HUM price reaction

HUM last traded at $410.84, up $30.52 (+8.02%) from the previous close of $380.32. The session traded on 0.6× average volume (below avg), so participation was unremarkable. Over the past month the stock has ranged between $372.00 and $410.84, and it currently sits about 100% of the way up that band.

Bullish and bearish analyst opinions on Humana Inc. (HUM)

Latest catalyststrengthens the bull case
The latest catalyst — a materially positive development — it strengthens the bull case and confirms the prevailing bullish analyst lean.

The consensus analyst price target on Humana Inc. (HUM) is $424.21, 3.3% above the recent $410.84. Over the past 90 days analysts logged 3 upgrades, 9 maintains, and 1 downgrade. Here is how the bullish and bearish cases on HUM line up.

The bullish case

  • Wall Street's consensus price target of $424.21 implies +3.3% upside from $410.84.
  • The Street's most bullish target is $515.00 (+25.4%).
  • 3 analyst upgrades in the past 90 days, most recently Morgan Stanley to Equal Weight (2026-08-05).
  • Material positive event.
  • Strong 8.0% price move on light volume.

The bearish case

  • The most bearish analyst target is $300.00 (-27.0%).
  • 1 analyst downgrade in the past 90 days, most recently Raymond James to Market Perform (2026-07-30).
  • Humana filed earnings today along with two material event 8-K filings (hum-20260728.htm and hum-20260729.htm), triggering a sharp 7.75% intraday decline to $358.60.
  • Humana Inc. (HUM) moved -5.22% from $407.78 to $386.48 on 2026-07-16.
Bull vs bear balanceBullish Shift
BearishNeutralBullish
The latest catalyst moved the balance toward the bulls — the hollow tick marks where it sat before.

Weighing both sides, BestStocks' composite read of recent signals is bullish, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.

Analyst price targets and ratings are FMP consensus figures as of Sep 25, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.

Analyst expectations
Consensus target: $424+3.3%
↑ 3 upgrades= 9 maintains↓ 1 downgrades
JP Morgan maintained Neutral · 2026-08-10
SEC filings watch
8-K2026-07-29
Material event — review for impact
high
8-K2026-07-29
Material event — review for impact
high
10-Q2026-07-29
Quarterly financial results
medium
8-K2026-06-01
Material event — review for impact
high
Peer context
HUM+8.0%

Previous notable changes for HUM

Valuation2026-09-21-2.0%via investing.com ↗
Humana shares declined 2.17% to $377.83 intraday, primarily driven by cautious investor sentiment over Medicare Advantage margin pressures and CMS policy limiting payment rate increases to 0.09%, according to the web catalyst. Volume traded 206,821 shares by the 200-minute mark—0.42x the expected average for this time of day, indicating below-average participation.
Material / Earnings2026-09-16-3.0%
Humana Inc. (HUM) moved -2.99% from $396.41 to $384.54 on 2026-09-16. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume was near its 5-day average at 1.2x, indicating no unusual trading activity.
Valuation2026-09-10+0.2%via Yahoo Finance ↗
Humana (HUM) rose 2.66% to $410.67, driven by reaffirmed full-year adjusted EPS guidance of at least $9.00 and continued strength in Medicare Advantage demand, according to the web catalyst. The stock is building on steady operational momentum despite earlier membership cuts affecting 600,000 members.
Material / Earnings2026-09-09-0.8%
Humana Inc. (HUM) moved -4.04% from $416.84 to $400.02 on 2026-09-09. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume was near its 5-day average, suggesting the move was not driven by unusual trading activity.

In-depth HUM event analyses

Permanent, dated analyses of HUM's most significant sessions.
Upcoming catalysts & outlook
Next earnings
2026-11-06 (est.)
in 42 days
Earnings Release
2026-11-06
High impact
Thesis shift
Bullish Shift
bullish signal
Risk level
High
from change events

Frequently asked questions about HUM

Why did Humana Inc. (HUM) stock move?

HUM climbed 8.0% to $410.84. The move coincided with the context summarized above, though no single company-specific catalyst was independently confirmed.

How much did HUM stock rise?

HUM gained 8.02% ($30.52) versus the prior close of $380.32, last trading at $410.84 on 0.6× average volume.

When is Humana Inc.'s next earnings date?

HUM's next earnings report is estimated for 2026-11-06 — about 42 days away.

What is the analyst price target for HUM?

The consensus analyst price target for HUM is $424.21, about 3.3% above the current $410.84. Over the past 90 days, analysts recorded 3 upgrades, 9 maintains, and 1 downgrade.

How BestStocks tracks HUM

This page is generated automatically by BestStocks' change-detection system after its price and volume cleared HUM-specific materiality thresholds, triggering an evidence check. It draws on 20 tracked change events for HUM, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of September 25, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.

Data sources
FMP real-time & historical price dataSEC EDGAR filingsFMP earnings & estimatesAnalyst ratings & price targets (FMP)Earnings calendar (FMP)
Educational research tool — not personalized investment advice. Data may be delayed.